Unlocking today’s possibilities for tomorrow’s cure
At GAIASO Theranostics, we are transforming outcomes in women’s cancer by developing precision radiotheranostics that help clinicians see, select and treat disease more effectively. Our integrated platform is designed to support earlier diagnosis and more precise treatment for women, addressing critical gaps in breast and gynaecological cancers where unmet need remains unacceptably high.
Smarter science. Stronger women.
Why We Exist
Female cancers remain critically underserved by modern oncology. GAIASO exists to change that by designing radiotheranostic solutions that recognise biological difference, address unmet need, and put women at the centre of cancer care.
Led by Experience. Guided by Purpose.
GAIASO is led by an experienced leadership team and supported by world‑class scientific and clinical advisors, bringing together expertise across oncology, radiopharmaceutical development and translational medicine.
Science Designed to Heal
A Focused, High‑Impact Pipeline
We are advancing a deliberately focused pipeline of theranostic programs for female cancers with the greatest unmet need – from early diagnosis to targeted treatment.
Each program is designed with translational intent, clinical relevance, and precision at its core.
Our approach combines deep biological insight with molecular engineering to deliver targeted radiotherapy that maximises tumour impact while minimising off‑target effects.
This is theranostics designed for precision, safety and scalability.